B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(2018) In Vascular Pharmacology 111. p.54-61- Abstract
Objective: Intranasal immunization with a fusion protein of the ApoB100-derived peptide p210 and the cholera toxin B subunit (CTB-p210) has previously been shown to induce mucosal tolerance and reduce atherosclerosis development, but the exact mode of action remains to be elucidated. Recent studies have indicated an important role for B cells in mucosal tolerance, in particular by induction of regulatory B (Bregs) and T cells (Tregs). In this study, we aimed to investigate if transfer of B cells pulsed with CTB-p210 can protect against atherosclerosis. Method and results: First, we studied if CTB-p210 can induce Bregs and Tregs in vitro. After pulsing B cells from Apobtm2Sgyldlr−/− or Apoe−/− mice with... (More)
Objective: Intranasal immunization with a fusion protein of the ApoB100-derived peptide p210 and the cholera toxin B subunit (CTB-p210) has previously been shown to induce mucosal tolerance and reduce atherosclerosis development, but the exact mode of action remains to be elucidated. Recent studies have indicated an important role for B cells in mucosal tolerance, in particular by induction of regulatory B (Bregs) and T cells (Tregs). In this study, we aimed to investigate if transfer of B cells pulsed with CTB-p210 can protect against atherosclerosis. Method and results: First, we studied if CTB-p210 can induce Bregs and Tregs in vitro. After pulsing B cells from Apobtm2Sgyldlr−/− or Apoe−/− mice with CTB-p210 for 1 h and co-culturing them with naïve T cells for 48 h, we observed increased expression of membrane bound TGFβ/latency-associated peptide (mTGFβ/LAP) on B cells and an increased proportion of CD25hiFoxP3+ Tregs. Adoptive transfer of B cells pulsed with CTB-p210 into high-fat diet-fed Apoe−/− mice at 8, 10 and 12 weeks of age, reduced the plaque area in the aorta at 20 weeks of age as compared with control-treated (CTB-pOVA treated B cells or PBS) mice. Moreover, mice receiving p210-CTB treated B cells had increased levels of anti-p210 IgG antibodies. Conclusion: Our observations suggest that CTB-p210 pulsed B cells acquire a regulatory phenotype and induce Tregs in vitro. Adoptive transfer of CTB-p210, but not control-treated, B cells into Apoe−/− mice decreased atherosclerosis development.
(Less)
- author
- organization
- publishing date
- 2018-09-19
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Atherosclerosis, Regulatory B cells, Regulatory T cells, Tolerance
- in
- Vascular Pharmacology
- volume
- 111
- pages
- 54 - 61
- publisher
- Elsevier
- external identifiers
-
- pmid:30243560
- scopus:85054176765
- ISSN
- 1537-1891
- DOI
- 10.1016/j.vph.2018.09.002
- language
- English
- LU publication?
- yes
- id
- e116e972-d1bb-44c3-993d-a91f6f6c74c7
- date added to LUP
- 2018-10-22 10:31:00
- date last changed
- 2024-08-20 02:01:18
@article{e116e972-d1bb-44c3-993d-a91f6f6c74c7, abstract = {{<p>Objective: Intranasal immunization with a fusion protein of the ApoB100-derived peptide p210 and the cholera toxin B subunit (CTB-p210) has previously been shown to induce mucosal tolerance and reduce atherosclerosis development, but the exact mode of action remains to be elucidated. Recent studies have indicated an important role for B cells in mucosal tolerance, in particular by induction of regulatory B (Bregs) and T cells (Tregs). In this study, we aimed to investigate if transfer of B cells pulsed with CTB-p210 can protect against atherosclerosis. Method and results: First, we studied if CTB-p210 can induce Bregs and Tregs in vitro. After pulsing B cells from Apob<sup>tm2Sgy</sup>ldlr<sup>−/−</sup> or Apoe<sup>−/−</sup> mice with CTB-p210 for 1 h and co-culturing them with naïve T cells for 48 h, we observed increased expression of membrane bound TGFβ/latency-associated peptide (mTGFβ/LAP) on B cells and an increased proportion of CD25<sup>hi</sup>FoxP3<sup>+</sup> Tregs. Adoptive transfer of B cells pulsed with CTB-p210 into high-fat diet-fed Apoe<sup>−/−</sup> mice at 8, 10 and 12 weeks of age, reduced the plaque area in the aorta at 20 weeks of age as compared with control-treated (CTB-pOVA treated B cells or PBS) mice. Moreover, mice receiving p210-CTB treated B cells had increased levels of anti-p210 IgG antibodies. Conclusion: Our observations suggest that CTB-p210 pulsed B cells acquire a regulatory phenotype and induce Tregs in vitro. Adoptive transfer of CTB-p210, but not control-treated, B cells into Apoe<sup>−/−</sup> mice decreased atherosclerosis development.</p>}}, author = {{Rattik, Sara and Mantani, Polyxeni T. and Yao Mattisson, Ingrid and Ljungcrantz, Irena and Sundius, Lena and Björkbacka, Harry and Terrinoni, Manuela and Lebens, Michael and Holmgren, Jan and Nilsson, Jan and Wigren, Maria and Nordin Fredrikson, Gunilla}}, issn = {{1537-1891}}, keywords = {{Atherosclerosis; Regulatory B cells; Regulatory T cells; Tolerance}}, language = {{eng}}, month = {{09}}, pages = {{54--61}}, publisher = {{Elsevier}}, series = {{Vascular Pharmacology}}, title = {{B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice}}, url = {{http://dx.doi.org/10.1016/j.vph.2018.09.002}}, doi = {{10.1016/j.vph.2018.09.002}}, volume = {{111}}, year = {{2018}}, }